Table 2

Hospitalisations with various conditions and all-cause mortality

 Number of events (%)*Unadjusted relative risk (95% CI)Adjusted relative risk (95% CI) †
Clarithromycin
n=52 251
Azithromycin
n=46 618
Acute kidney injury52 (0.10)44 (0.09)1.05 (0.71 to 1.58)1.06 (0.71 to 1.58)
Myocardial infarction39 (0.07)30 (0.06)1.16 (0.72 to 1.87)1.15 (0.71 to 1.85)
Neuroimaging‡582 (1.11)496 (1.06)1.05 (0.93 to 1.18)1.04 (0.93 to 1.18)
Hypotension19 (0.04)14 (0.03)1.21 (0.61 to 2.42)1.21 (0.61 to 2.41)
Syncope14 (0.03)12 (0.03)1.04 (0.48 to 2.25)1.04 (0.48 to 2.25)
Hyperkalaemia9 (0.02)12 (0.03)0.67 (0.28 to 1.59)0.67 (0.28 to 1.60)
Hyponatraemia29 (0.06)29 (0.06)0.89 (0.53 to 1.49)0.90 (0.54 to 1.51)
Hyperglycaemia22 (0.04)16 (0.03)1.23 (0.64 to 2.34)1.22 (0.64 to 2.33)
Arrhythmia49 (0.09)52 (0.11)0.84 (0.57 to 1.24)0.84 (0.57 to 1.24)
Ischaemic stroke17 (0.03)16 (0.3)0.95 (0.48 to 1.88)0.94 (0.47 to 1.86)
Gastrointestinal bleeding32 (0.06)30 (0.06)0.95 (0.58 to 1.57)0.95 (0.58 to 1.56)
Sepsis28 (0.05)18 (0.04)1.39 (0.77 to 2.51)1.38 (0.76 to 2.49)
All-cause mortality241 (0.46)172 (0.37)1.25 (1.03 to 1.52)1.27 (1.04 to 1.55)
  • Patients prescribed azithromycin served as the comparator group.

  • *The number of events (and the proportion of patients who experienced an event) for all outcomes except all-cause mortality was assessed by hospital diagnosis codes. For some outcomes, this underestimates the true event rate because these codes have high specificity but low sensitivity.

  • †Adjusted for three covariates: age, sex and Charlson comorbidity score.

  • ‡Neuroimaging consisted of codes for CI head scan as a proxy for delirium.